Business Context and Reporting Period
Company: Champions Oncology, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: September 11, 2024
Reporting Period: First quarter ended July 31, 2024
Context: The filing serves to announce the issuance of a press release containing unaudited financial results for the quarter ended July 31, 2024. The detailed financial data is contained in Exhibit 99.1 (Press Release) and is not embedded directly in the text of this 8-K form.
Key Financial Metrics
The provided text of the Form 8-K does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the attached press release (Exhibit 99.1) but are not present in the filing text itself.
Material Changes
No material changes or comparative financial data versus prior periods are detailed in the text of this filing. The document solely references the release of the Q1 2024 results.
Guidance, Outlook, and Risks
Management Commentary: The filing notes the release of unaudited results but does not include specific management commentary, guidance, or outlook within the 8-K text.
Risks and Contingencies: No specific risks or contingencies are described in this filing text.
Unusual Items: None reported in the text of this filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated September 11, 2024) for actual revenue, net loss, and cash position figures.
- Verify the unaudited nature of the financial results for the quarter ended July 31, 2024.
- Check for any forward-looking statements or updated guidance within the attached press release.
- Note the discrepancy in the signature date (March 12, 2024) versus the report date (September 11, 2024) and confirm if this reflects a filing error or specific authorization timing.